General Information of the Compound
Compound ID
CP0506428
Compound Name
PHA568487
    Show/Hide
Synonyms
PHA-568487
    Show/Hide
Structure
Formula
C16H20N2O3
Molecular Weight
288.347
Canonical SMILES
O=C(N[C@H]1CN2CCC1CC2)c1ccc2OCCOc2c1
    Show/Hide
InChI
InChI=1S/C16H20N2O3/c19-16(17-13-10-18-5-3-11(13)4-6-18)12-1-2-14-15(9-12)21-8-7-20-14/h1-2,9,11,13H,3-8,10H2,(H,17,19)/t13-/m0/s1
    Show/Hide
InChIKey
LUVXHMJTVXZFPD-ZDUSSCGKSA-N
Physicochemical Property
logP
1.2818
Rotatable Bonds
2
Heavy Atom Count
21
Polar Areas
50.8
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9932000
SID: 15114985
ChEMBL ID
CHEMBL2086586
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02118, Neuronal acetylcholine receptor subunit alpha-7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000029 GH4C1 Rattus norvegicus (Rat)  1
1
EC50 = 36.2 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PHA-568487 )
Drug Name PHA-568487
Company Pfizer Inc
Indication
Cognitive impairment
Preclinical
Target(s)
Neuronal acetylcholine receptor alpha-7 (CHRNA7)
Agonist